Description
Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Oxcarbazepine Tablets |
| Strength | 300?mg (0.3?g) |
| Formulation | Oral tablet |
| Pack Size | 50 tablets per box |
| CAS Number | 28721-07-5 |
| Molecular Formula | C??H??N?O? |
| Molecular Weight | 252.27 g/mol |
| Drug Approval No. | H20244663 (NMPA – China) |
| Product Code | 86909568000401 |
| Manufacturer | Chongqing Synrex Pharmaceutical Co., Ltd. |
| Dosage Form | Tablet |
| Package Barcode | Not Provided |
| Storage Conditions | Store in a cool, dry place below 25?°C |
| Intended Use | Laboratory research only |
| Shelf Life | 24 months from manufacturing date |
Mechanism of Action
Oxcarbazepine is a structural derivative of carbamazepine and acts by blocking voltage-sensitive sodium channels in neuronal membranes. It stabilizes hyperexcited neural tissue and inhibits repetitive firing, making it an effective molecule in epilepsy and neuroprotection studies.
Research Applications
Epilepsy Models
Commonly used in rodent seizure models to investigate anticonvulsant effects and sodium channel modulation.Neuropathic Pain Studies
Evaluated for efficacy in chronic nerve pain models due to its impact on neural excitability.Comparative Pharmacology
Compared with carbamazepine and newer antiepileptic agents for efficacy and safety profiles.Pharmacokinetics & Drug Metabolism
Useful in ADME (absorption, distribution, metabolism, and excretion) studies in preclinical trials.
Core Keywords
Oxcarbazepine tablets, CAS 28721-07-5, Oxcarbazepine 300mg, antiepileptic research, CNS sodium channel blocker, epilepsy lab compound, wholesale Oxcarbazepine, lab-use anticonvulsants, Chongqing Synrex, neuroscience drug testing
Research Use Only Disclaimer
This product is intended exclusively for laboratory research purposes. It is not approved for use in humans or animals. Always follow local and institutional safety protocols when handling experimental pharmaceuticals.


Reviews
There are no reviews yet.